New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 1, Pages 69-77
Publisher
Informa Healthcare
Online
2013-10-08
DOI
10.1517/14728222.2013.843670
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies
- (2013) Antonella Caccamo et al. AGING CELL
- Dynamics of Hippocampal Neurogenesis in Adult Humans
- (2013) Kirsty L. Spalding et al. CELL
- Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
- (2013) Undine E. Lang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Understanding the relationship between GSK-3 and Alzheimer’s disease: a focus on how GSK-3 can modulate synaptic plasticity processes
- (2013) Miguel Medina et al. Expert Review of Neurotherapeutics
- DISC1-related signaling pathways in adult neurogenesis of the hippocampus
- (2013) Qian Wu et al. GENE
- Alzheimer’s disease and insulin resistance: translating basic science into clinical applications
- (2013) Fernanda G. De Felice JOURNAL OF CLINICAL INVESTIGATION
- GSK-3β overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo
- (2013) M Llorens-Martín et al. MOLECULAR PSYCHIATRY
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
- (2013) T. Wyss-Coray et al. Cold Spring Harbor Perspectives in Medicine
- Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease
- (2012) Miguel Medina et al. CURRENT PHARMACEUTICAL DESIGN
- Dual effects of increased glycogen synthase kinase-3β activity on adult neurogenesis
- (2012) Almudena Fuster-Matanzo et al. HUMAN MOLECULAR GENETICS
- Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model
- (2012) Limor Avrahami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
- (2012) Philip T.T. Ly et al. JOURNAL OF CLINICAL INVESTIGATION
- Selectively Silencing GSK-3 Isoforms Reduces Plaques and Tangles in Mouse Models of Alzheimer's Disease
- (2012) D. E. Hurtado et al. JOURNAL OF NEUROSCIENCE
- Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid- Precursor Protein
- (2012) C. Parr et al. MOLECULAR AND CELLULAR BIOLOGY
- A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer's disease
- (2012) Marcelo A. Alarcón et al. NEUROBIOLOGY OF AGING
- The Age of Olfactory Bulb Neurons in Humans
- (2012) Olaf Bergmann et al. NEURON
- Selective deletion of forebrain glycogen synthase kinase 3 reveals a central role in serotonin-sensitive anxiety and social behaviour
- (2012) C. Latapy et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
- (2012) Ronald S. Duman et al. TRENDS IN NEUROSCIENCES
- Neurological Functions of the Masterswitch Protein Kinase – Gsk-3
- (2012) Oksana Kaidanovich-Beilin et al. Frontiers in Molecular Neuroscience
- New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
- (2012) Michael Maes et al. INFLAMMOPHARMACOLOGY
- DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness
- (2011) Dinesh C. Soares et al. ACS Chemical Neuroscience
- Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- (2011) Orestes V. Forlenza et al. BRITISH JOURNAL OF PSYCHIATRY
- Identification and characterization of neuroblasts in the subventricular zone and rostral migratory stream of the adult human brain
- (2011) Congmin Wang et al. CELL RESEARCH
- Neurodegenerative disease and adult neurogenesis
- (2011) Beate Winner et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Inhibition of GSK3 improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome
- (2011) W. Guo et al. HUMAN MOLECULAR GENETICS
- A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
- (2011) Jean-Martin Beaulieu JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Gone with the wean
- (2011) Jon I. Arellano et al. NATURE
- GSK-3α/β kinases and amyloid production in vivo
- (2011) Tomasz Jaworski et al. NATURE
- Corridors of migrating neurons in the human brain and their decline during infancy
- (2011) Nader Sanai et al. NATURE
- Tissue-Specific Analysis of Glycogen Synthase Kinase-3α (GSK-3α) in Glucose Metabolism: Effect of Strain Variation
- (2011) Satish Patel et al. PLoS One
- Different Susceptibility to Neurodegeneration of Dorsal and Ventral Hippocampal Dentate Gyrus: A Study with Transgenic Mice Overexpressing GSK3β
- (2011) Almudena Fuster-Matanzo et al. PLoS One
- Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies
- (2011) Miguel Medina et al. Frontiers in Molecular Neuroscience
- Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease
- (2010) Koen Bossers et al. BRAIN
- Hyperactivity and Enhanced Curiosity of Mice Expressing PKB/SGK-resistant Glycogen Synthase Kinase-3 (GSK-3)
- (2010) Teresa F. Ackermann et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Neurogenesis and Alzheimers Disease: Biology and Pathophysiology in Mice and Men
- (2010) M. Marlatt et al. Current Alzheimer Research
- Glycogen synthase kinase-3β, or a link between amyloid and tau pathology?
- (2010) D. Muyllaert et al. GENES BRAIN AND BEHAVIOR
- Inflammation in neurodegenerative diseases
- (2010) Sandra Amor et al. IMMUNOLOGY
- The secretases: enzymes with therapeutic potential in Alzheimer disease
- (2010) Bart De Strooper et al. Nature Reviews Neurology
- GSK3 signalling in neural development
- (2010) Eun-Mi Hur et al. NATURE REVIEWS NEUROSCIENCE
- Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
- (2010) Xiaohua Li et al. NEUROPSYCHOPHARMACOLOGY
- Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease
- (2010) Oyinkan Sofola et al. PLoS Genetics
- Fragile X Mental Retardation Protein Regulates Proliferation and Differentiation of Adult Neural Stem/Progenitor Cells
- (2010) Yuping Luo et al. PLoS Genetics
- Mechanisms of tau-induced neurodegeneration
- (2009) Khalid Iqbal et al. ACTA NEUROPATHOLOGICA
- Blocked Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3α/β Impairs In Vivo Neural Precursor Cell Proliferation
- (2009) Tae-Yeon Eom et al. BIOLOGICAL PSYCHIATRY
- On whether the environmental enrichment may provide cognitive and brain reserves
- (2009) Laura Petrosini et al. BRAIN RESEARCH REVIEWS
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
- (2009) Yingwei Mao et al. CELL
- GSK3: A possible link between beta amyloid peptide and tau protein
- (2009) Félix Hernández et al. EXPERIMENTAL NEUROLOGY
- Neurogenesis and Alzheimer's disease: At the crossroads
- (2009) Orly Lazarov et al. EXPERIMENTAL NEUROLOGY
- GSK-3: A key player in neurodegeneration and memory
- (2009) Karl Peter Giese IUBMB LIFE
- Αβ Hinders Nuclear Targeting of AICD and Fe65 in Primary Neuronal Cultures
- (2009) A. G. Henriques et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- GSK-3 is a master regulator of neural progenitor homeostasis
- (2009) Woo-Yang Kim et al. NATURE NEUROSCIENCE
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
- (2009) Kurt R. Brunden et al. NATURE REVIEWS DRUG DISCOVERY
- Adult-Generated Hippocampal Neurons Allow the Flexible Use of Spatially Precise Learning Strategies
- (2009) Alexander Garthe et al. PLoS One
- Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
- (2009) Oksana Kaidanovich-Beilin et al. Molecular Brain
- Amyloid-β Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/β-Catenin Signaling
- (2008) Margaret H. Magdesian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Non-Cell-Autonomous Effects of Presenilin 1 Variants on Enrichment-Mediated Hippocampal Progenitor Cell Proliferation and Differentiation
- (2008) Se Hoon Choi et al. NEURON
- GSK-3β Is Required for Memory Reconsolidation in Adult Brain
- (2008) Tetsuya Kimura et al. PLoS One
- Role of GSK3 in behavioral abnormalities induced by serotonin deficiency
- (2008) J.-M. Beaulieu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now